DOGWOOD PHARMACEUTICALS INC has a total of 16 patent applications. Its first patent ever was published in 2004. It filed its patents most often in Australia, EPO (European Patent Office) and Hungary. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are GTX INC, PHARMACIA CORP and METABOLIC SOLUTIONS DEV CO LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 5 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Hungary | 2 | |
#4 | Israel | 2 | |
#5 | Canada | 1 | |
#6 | Malaysia | 1 | |
#7 | Ukraine | 1 | |
#8 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Acyclic or carbocyclic compounds | |
#5 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Thompson Robert D | 9 |
#2 | Rieger Jayson M | 9 |
#3 | Zuck Karina | 5 |
#4 | Padia Janak | 5 |
#5 | Strovel Jeffrey | 5 |
#6 | Ohler Zoe | 5 |
#7 | Watthey Jeffrey W H | 5 |
#8 | Cholody Wieslaw M | 5 |
#9 | Zang Yi | 5 |
#10 | Wang Guoquan | 5 |
Publication | Filing date | Title |
---|---|---|
AU2014233555A1 | Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereof | |
EP1658291A2 | Substituted 8-heteroaryl xanthines |